About Us
Management Team
Manuel Sturzbecher-Höhne, PhD
Chief Technology Officer
Manuel is a leading expert in radiopharmaceutical development, with extensive experience in Chemistry, Manufacturing and Controls (CMC), regulatory compliance, clinical manufacturing and supply chain management. As Chief Technology Officer of Ariceum Therapeutics, he oversees manufacturing, formulation, and development strategies, ensuring the highest standards in next-generation radiopharmaceutical innovation.
Prior to joining Ariceum Therapeutics in 2021, Manuel served as CMC/Site Head at OctreoPharm Sciences GmbH, an Ipsen company, where he was responsible for cGMP and cGRPP-compliant manufacturing of radiopharmaceuticals for clinical trials.
Manuel received his Ph.D. in Chemistry at the ETH Zurich, Switzerland, before becoming a post-doctoral fellow and scientist at the Berkeley Laboratory in California, where he focused on the research and development of actinide decorporation agents and investigated biochemical pathways of radionuclides.
© Ariceum Therapeutics
